• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

CD164

The slower kinetics and low efficiency of reprogramming solutions to generate

November 22, 2018 by Katherine Lewis Leave a Comment

The slower kinetics and low efficiency of reprogramming solutions to generate human induced pluripotent stem cells (iPSCs) impose major restrictions on the utility in biomedical applications. where tumor suppressors could CD164 be inhibited and oncogenic pathways could be turned on. Though recent research have reported a better performance of reprogramming by hereditary manipulations4 as well … [Read more…]

Posted in: Blogging Tagged: BIBR-1048, CD164

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by